Fiera Capital Corp Exelixis, Inc. Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 22, 2024	SELL	$19.25 - $24.13 $47,124 - $59,070	-2,448 Reduced 2.05%	116,942 $2.81 Million
Q4 2023 Feb 08, 2024	SELL	$19.25 - $24.13 $47,124 - $59,070	-2,448 Reduced 2.05%	116,942 $2.81 Million
Q3 2023 Aug 22, 2024	BUY	$19.04 - $22.74 $2.27 Million - $2.71 Million	119,390 New	119,390 $2.61 Million
Q1 2023 Apr 26, 2023	SELL	$16.3 - $19.41 $38.7 Million - $46 Million	-2,371,186 Reduced 95.21%	119,390 $2.32 Million
Q4 2022 Feb 08, 2023	SELL	$14.96 - $17.39 $1.62 Million - $1.88 Million	-107,997 Reduced 4.16%	2,490,576 $39.9 Million
Q3 2022 Nov 03, 2022	SELL	$15.68 - $22.27 $1.43 Million - $2.03 Million	-90,975 Reduced 3.38%	2,598,573 $37.2 Million
Q2 2022 Aug 10, 2022	SELL	$17.44 - $23.16 $769,679 - $1.02 Million	-44,133 Reduced 1.61%	2,689,548 $56 Million
Q1 2022 May 09, 2022	BUY	$17.03 - $22.67 $1.68 Million - $2.24 Million	98,598 Added 3.74%	2,733,681 $62 Million
Q4 2021 Feb 08, 2022	BUY	$15.84 - $21.88 $3.35 Million - $4.63 Million	211,554 Added 8.73%	2,635,083 $48.2 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $627,354 - $813,636	-38,488 Reduced 1.56%	2,423,529 $51.2 Million
Q2 2021 Aug 11, 2021	SELL	$17.95 - $25.56 $1.21 Million - $1.72 Million	-67,340 Reduced 2.66%	2,462,017 $58.4 Million
Q1 2021 May 11, 2021	SELL	$20.53 - $25.22 $617,809 - $758,945	-30,093 Reduced 1.18%	2,529,357 $57.1 Million
Q4 2020 Feb 09, 2021	SELL	$18.39 - $24.8 $187,412 - $252,736	-10,191 Reduced 0.4%	2,559,450 $51.4 Million
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $1.42 Million - $1.85 Million	-68,773 Reduced 2.61%	2,569,641 $62.8 Million
Q2 2020 Aug 07, 2020	SELL	$16.46 - $27.42 $1.02 Million - $1.71 Million	-62,214 Reduced 2.3%	2,638,414 $62.6 Million
Q1 2020 May 08, 2020	BUY	$14.46 - $21.8 $305,959 - $461,266	21,159 Added 0.79%	2,700,628 $46.5 Million
Q4 2019 Feb 06, 2020	SELL	$15.15 - $18.89 $4.29 Million - $5.34 Million	-282,848 Reduced 9.55%	2,679,469 $47.2 Million
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $1.76 Million - $2.25 Million	-99,392 Reduced 3.25%	2,962,317 $52.4 Million
Q2 2019 Aug 12, 2019	BUY	$18.93 - $24.75 $11.5 Million - $15 Million	606,116 Added 24.68%	3,061,709 $65.4 Million
Q1 2019 May 10, 2019	BUY	$19.6 - $24.76 $8.9 Million - $11.2 Million	454,100 Added 22.69%	2,455,593 $58.4 Million
Q4 2018 Feb 12, 2019	BUY	$13.65 - $21.8 $27.3 Million - $43.6 Million	2,001,493 New	2,001,493 $39.4 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.14 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$995 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$862 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$521 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$388 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account